![5000100-flag[1].jpg](https://cdn.european-virus-archive.com/cdn/farfuture/BIcd6Z7a1Uzb5LahErSGdoyqhDpItm5zvumsM9sBY60/mtime:1484756601/sites/default/files/5000100-flag%5B1%5D.jpg)
The best way to get viral material within the Scientific Community. Browse our viruses and derived products from the EVAg Portal.
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
An international group of 25 laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
An open entity aiming at developing synergies and complementary capabilities in such a way as to offer an improved access to researchers.
The quality of viruses and derived products is a key consideration when our products are to be made available. Improvements on quality process will be addressed during the project.
EVAg generates and distributes globally diagnostic materials and protocols in the event of epidemiological emergencies.
Focused on the creation of new tools, techniques and concepts to develop the infrastructure and to provide easier and less expensive access to virological materials.
A user-friendly web Portal with a continuously increasing number of viruses and derived products. Start here...
The EVAg initiative will increase competitiveness and, provides for a strong interaction with industry and a promising foundation for the innovation process between academia and industry.
- The European Commission -
The initiative has an important social impact with particular emphasis on human disease.
- The European Commission -
The quality of the installations cooperating in this consortium is excellent, representing some of the best available infrastructures across the EU and world-wide.
- The European Commission -
Check out our latest consortium paper if you're interested about our work :) https://t.co/1pNzrclaZq https://t.co/NBnbWfYqGX
Great news: our partner from Wuhan Institute of Virology just shared some of their large antibody collection against RG4 viruses, MERS, and notably Nipah virus. You can check them out on our catalogue: https://t.co/2vOswGM1uO https://t.co/dsE0u103tM
Interesting new perspective on #Alzheimer disease and #Herpesvirus: Aβ binds and agglutinates HSV1 and HHV6 viruses. Read the first paper too, from Readhead et al. You can access our collection of HSV1 and HHV6 viruses via our catalogue: https://t.co/3RYHEwboi2 https://t.co/NxOKWyKcJf
Our Australian partner CSIRO had just added to the EVAg catalogue a strain of NIPAH virus and HENDRA virus. It's great to see such a rapid mobilization and response of our consortium to viral World news ! You can order them via our online catalogue:https://t.co/Rl3RCvFPJ0
@VignuzziLab didactically explaining to the audience here at #31stICAR #antivirals2018 @ISARICAR in Porto, the evolution on the viral fitness landscape https://t.co/9NIVXVEP0g
Join us at #antivirals2018 @ISARICAR in Porto ! The meeting is about to start with the keynote address by Annelies Wilder-Smith, @ZikaPLAN coordinator. Arboviruses in the spotlights ! https://t.co/qE9KYJ5xaR
A one-day workshop was organised by our EVAg partner Animal and Plant Health Agency, APHA on the 15th of October, 2016. The aim of this workshop was t... read more
The next American Society of Tropical Medicine and Hygiene Annual Meeting will be held in November 13-17, 2016, in Atlanta, Georgia, USA.... read more
The World Health Organisation (WHO) has warned that Zika virus (ZIKV), a mosquito-borne virus that can infect humans, is likely to spread across the ... read more
We at Luminex were sincerely appreciative of your willingness to work with us during the development of our xMAP® MultiFLEX™ Zika RNA Assay. The materials from EVAg supported our FDA submission, which is now authorized for emergency use.
Sarah M. Dunlap, PhDDirector, Clinical Operations - Luminex Corporation
We received high quality products at no cost. It helped us a lot in achieving our project. Thank you!
John UserR & D - Laboratory
